Literature DB >> 28381948

Risk Stratification for Esophageal Adenocarcinoma Screening and Surveillance.

Stuart Jon Spechler1, M Berta1, Cecil O Patterson1.   

Abstract

Entities:  

Year:  2006        PMID： 28381948      PMCID： PMC5368617     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Optical biopsy: a new frontier in endoscopic detection and diagnosis.

Authors:  Thomas D Wang; Jacques Van Dam
Journal:  Clin Gastroenterol Hepatol       Date:  2004-09       Impact factor: 11.382

2.  Should patients with GERD be screened once at least for Barrett's epithelium? A balancing view: To screen or not to screen: scoping out the issues.

Authors:  Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

Review 3.  Dysplasia in Barrett's esophagus: limitations of current management strategies.

Authors:  Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2005-04       Impact factor: 10.864

4.  The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus.

Authors:  Prateek Sharma; Ajay Bansal; Sharad Mathur; Sachin Wani; Rachel Cherian; Douglas McGregor; April Higbee; Sandra Hall; Allan Weston
Journal:  Gastrointest Endosc       Date:  2006-08       Impact factor: 9.427

Review 5.  Review article: screening and surveillance of Barrett's oesophagus: what is a cost-effective framework?

Authors:  S J Spechler; H Barr
Journal:  Aliment Pharmacol Ther       Date:  2004-02       Impact factor: 8.171
  5 in total
  2 in total

1.  Metabolic and Immunological Subtypes of Esophageal Cancer Reveal Potential Therapeutic Opportunities.

Authors:  Ryan J King; Fang Qiu; Fang Yu; Pankaj K Singh
Journal:  Front Cell Dev Biol       Date:  2021-07-08

2.  Pre-clinical dosimetry of a new six-channel applicator for high-dose-rate treatment of esophageal cancer.

Authors:  Anzi Zhao; Shengqiang Gao; John Greskovich; Douglas Allan Wilkinson
Journal:  J Contemp Brachytherapy       Date:  2021-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.